Skip to main content
Loading

Spotlight Presentation: Analytical Characterization of Oligonucleotides

26 Sep 2025
 Innovation in Therapeutic Modalities Translational & Clinical Strategy Oligonucleotide CMC & Process Development Peptide CMC & Process Development
Spotlight Presentation: Analytical Characterization of Oligonucleotides

Strategic application of advanced analytical techniques can help improve selection of candidates and guide development decisions, leading to a greater number of safer, more efficacious therapies successfully completing development and entering the market. ProtaGene offers a comprehensive suite of analytical platforms for characterizing complex biologics, providing insights into their structure, stability, and purity. 

Industry Expert
Vanessa Gill, Director of Analytical Development and CMC - ProtaGene US